Cyclacel Pharmaceuticals ... (CYCCP)
NASDAQ: CYCCP
· Real-Time Price · USD
5.50
0.08 (1.51%)
At close: Aug 15, 2025, 2:47 PM
5.97
8.55%
After-hours: Aug 15, 2025, 07:30 PM EDT
Cyclacel Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | -25K | -21K | 8K | 74K | 80K | 449K | 420K | 389K | 373K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 5K | 7K | 9K | 13K | 19K | 389.63K | 387.63K | 387.63K | 387.63K | 23K | 32K | 31K | 34K | 43K | 43K | 3.38M | 4.45M | 5.59M |
Gross Profit | -29K | -25K | 4K | 74K | 73K | 69.37K | 40.37K | 1.37K | -14.63K | -23K | -4.96M | -4.96M | -4.96M | -4.97M | -43K | -3.38M | -4.44M | -5.59M |
Operating Income | -9.04M | -12.69M | -12M | -15.54M | -20.2M | -22.49M | -25.45M | -28.94M | -28.56M | -28.42M | -27.66M | -25.34M | -24.88M | -25.19M | -22.94M | -19.57M | -16.14M | -12.52M |
Interest Income | 44K | 16K | 12K | 5K | 47K | 152K | 266K | 365K | 382K | 322K | 210K | 92K | 29K | 16K | 16K | 18K | 18K | 18K |
Pretax Income | -4.11M | -7.78M | -11.99M | -15.83M | -20.36M | -22.73M | -25.55M | -28.86M | -28.27M | -27.79M | -25.91M | -23.41M | -23.28M | -23.81M | -22.73M | -19.42M | -15.97M | -12.34M |
Net Income | -5.09M | -8.35M | -11.21M | -13.43M | -17.51M | -19.7M | -22.55M | -24.7M | -23.77M | -22.89M | -21.2M | -19.07M | -18.96M | -19.52M | -18.89M | -16.4M | -13.66M | -10.7M |
Selling & General & Admin | 6.4M | 8.02M | 5.39M | 6.32M | 6.71M | 6.66M | 6.72M | 6.99M | 7.42M | 7.42M | 7.38M | 7.18M | 6.91M | 7.33M | 7.46M | 7.27M | 6.99M | 6.3M |
Research & Development | 2.65M | 4.67M | 6.65M | 9.29M | 13.58M | 16.28M | 19.16M | 22.34M | 21.52M | 20.99M | 20.27M | 18.16M | 17.97M | 17.86M | 15.48M | 12.3M | 9.16M | 6.22M |
Other Expenses | 1K | 1K | 1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 9.05M | 12.7M | 12.05M | 15.61M | 20.28M | 22.94M | 25.87M | 29.33M | 28.93M | 28.42M | 27.66M | 25.34M | 24.88M | 25.19M | 22.94M | 19.57M | 16.14M | 12.52M |
Interest Expense | n/a | 28K | 28K | 28K | 28K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 9.05M | 12.7M | 12.05M | 15.61M | 20.28M | 22.94M | 25.87M | 29.33M | 28.93M | 28.42M | 27.66M | 25.34M | 24.88M | 25.19M | 22.94M | 19.57M | 16.14M | 12.52M |
Income Tax Expense | 984K | 572K | -3.71M | -5.32M | -5.78M | -5.96M | -3M | -4.16M | -4.5M | -4.9M | -4.72M | -4.33M | -4.32M | -4.3M | -3.85M | -3.03M | -2.31M | -1.63M |
Shares Outstanding (Basic) | n/a | 12.96K | 8.66M | 2.02M | 1.69M | 1.22M | 854.02K | 842.85K | 836.82K | 836.28K | 835.93K | 820.97K | 675.74K | 666.2K | 656.02K | 624.52K | 615.6K | 473.26K |
Shares Outstanding (Diluted) | n/a | 12.96K | 8.66M | 2.02M | 1.69M | 1.22M | 854.02K | 842.85K | 836.82K | 836.28K | 835.93K | 820.97K | 675.74K | 666.2K | 656.02K | 624.52K | 615.6K | 473.26K |
EPS (Basic) | -8.55 | -9.5 | -5.68 | -11.56 | -17.78 | -22.39 | -26.94 | -29.63 | -28.67 | -28.94 | -28.16 | -27.36 | -29.15 | -30.72 | -31.92 | -28.44 | -23.81 | -18.7 |
EPS (Diluted) | -8.55 | -9.5 | -5.68 | -11.56 | -17.78 | -22.39 | -26.94 | -29.63 | -28.67 | -28.94 | -28.16 | -27.36 | -29.15 | -30.72 | -31.92 | -25.15 | -20.52 | -15.4 |
EBITDA | -9.1M | -12.74M | -12.05M | -15.52M | -20.18M | -22.46M | -25.42M | -28.91M | -28.53M | -28.39M | -27.62M | -25.27M | -24.8M | -25.11M | -22.85M | -19.53M | -16.11M | -12.49M |
EBIT | -9.1M | -12.74M | -12.06M | -15.53M | -20.2M | -22.49M | -25.45M | -28.94M | -28.56M | -28.42M | -27.66M | -25.3M | -24.83M | -25.15M | -22.89M | -19.57M | -16.14M | -12.52M |
Depreciation & Amortization | 3.5K | 5.5K | 6K | 13K | 19K | 25K | 31K | 31K | 31K | 31K | 32K | 31K | 34K | 43K | 43K | 40K | 36K | 24K |